Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) traded at $6.53 at last check on Monday, Jun 29, making an upward move of 4.9% on its previous day’s price.

Looking at the stock we see that its previous close was $6.22 and the beta (5Y monthly) reads 0.97 with the day’s price range being $6.26 – 6.65. In terms of its 52-week price range, MDRX has a high of $11.87 and a low of $4.56. The company’s stock has gained about 3.24% over that past 30 days.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $401.22 Million, with a low of $375Million and a high of $421.7 Million. The median projection represents growth adding up to -9.8% compared to sales earnings for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecasts for 2020 are expected to hit $1.7 Billion, or -4.3% down from figures reported last year.

On the other hand, looking at the outlook for the MDRX stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Based on estimates by 23 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 15 have rated the Allscripts Healthcare Solutions, Inc. (MDRX) stock as a Hold, while 6 rate it as a Buy. 1 analysts rate it as outperform while none of them rated it as underperform, whereas 1 suggests the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.

Let’s briefly compare Allscripts (MDRX) stock to its peers. We find that today’s price change of +4.9% and -43.9% over the past 12 months for MDRX competes that of Cerner Corp (CERN), which has seen its stock price rise 2.1% in the latest trading session and is -7.31% over the last one year. Another of its peers 10X Genomics Inc (TXG) has dropped -1.86% today, but is 0% down over the past year, while Livongo Health Inc (LVGO) is also up 4.9% yet its price remains in the red at -43.9% over the same period. Cerner has a P/E ratio of 42.22 compared to Allscripts’ 0 and 10X’s 0. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 2.32% and 1.47%, respectively, in early deals.

Coming back to Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), we note that the average 3-month trading volume was 2.47 Million, while that of the preceding 10-day period stands at 1.89 Million. Current shares outstanding are 162.55 Million.

According to data from Thomson Reuters, insiders hold 1.44% of the company’s shares while institutions hold 113.95%. The data shows that short shares as of June 14, 2020, stood at 17.7 Million at a short ratio of 8.77. This represents a 10.89% Short interest in Shares outstanding on June 14, 2020. Shares short dropped in June from the previous month at 18.64 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -33.52% down in year-to-date price movement.